GLP-1 Medications Made Simple: Ozempic, Wegovy, And Beyond
GLP-1 receptor agonists have emerged as a groundbreaking class of treatments for type 2 diabetes and obesity.
By Harbor Health Team
Dosing schedules, side effects, plateaus, and what happens after the last injection. Every article written and reviewed by Harbor’s medical team.

115 articles, page 10 of 10
Newest first

GLP-1 receptor agonists have emerged as a groundbreaking class of treatments for type 2 diabetes and obesity.
By Harbor Health Team

Ozempic and Wegovy are two brand-name medications that share the same active ingredient, yet they serve different primary purposes.
By Harbor Health Team

Tracking progress on weight loss medication can be challenging: you’re excited about results but worry about every fluctuation.
By Harbor Health Team

Semaglutide has emerged as a powerful tool for weight management, helping people shed significant pounds by curbing appetite and improving blood sugar control.
By Harbor Health Team

Ozempic (semaglutide) has rapidly become one of the most talked-about medications in health care.
By Harbor Health Team

The rise of GLP-1 weight loss treatments has revolutionized obesity care, offering a new level of effectiveness through once-weekly injections.
By Harbor Health Team

Tirzepatide works, with the 21% average weight loss seen in the SURMOUNT-1 trial, is unlike anything obesity medicine has produced before.
By Harbor Health Team
